Volume 30, Number 11—November 2024
Research Letter
Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia
Figure

Figure. Number of PRN-deficient isolates and frequency of fimbrial serotypes in a study of pertactin-deficient Bordetella pertussis isolates, Slovenia, 2002–2020. Vaccines in yellow boxes are those used for primary vaccination; those in the white box are used for booster vaccination. ACV, acellular pertussis vaccine; ACV PRN, ACV containing pertactin; ACV ∆PRN, ACV without pertactin; Fim, fimbriae; PRN, pertactin.
1These first authors contributed equally to this article.
Page created: September 30, 2024
Page updated: October 23, 2024
Page reviewed: October 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.